View in EDS HTML Full Text PDF Full Text

TMEM92 shields DDX3X from TTC3‐mediated degradation to confer chemoresistance in triple‐negative breast cancer.

Saved in:
Bibliographic Details
Title: TMEM92 shields DDX3X from TTC3‐mediated degradation to confer chemoresistance in triple‐negative breast cancer.
Authors: Shen, Hao1 (AUTHOR), Jia, Xiaochao2 (AUTHOR), Li, Xu3 (AUTHOR), Li, Zhi4 (AUTHOR), Zhang, Zhihua2 (AUTHOR), Zhao, Yang2 (AUTHOR), Shen, Lei1 (AUTHOR), Bu, Xiaoqiu1 (AUTHOR), Ma, Qiang1 (AUTHOR), Liang, Chunli1 (AUTHOR), Lin, Xiaoti1 (AUTHOR) linxt3@mail2.sysu.edu.cn, Ma, Lin‐Xiaoxi5,6 (AUTHOR) mary2008white@126.com, Qin, Chuan2 (AUTHOR) 18121157758@163.com
Source: Clinical & Translational Medicine. May2026, Vol. 16 Issue 5, p1-24. 24p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20011326
DOI:10.1002/ctm2.70681